STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy. | |
Wei-Jing Gong; Li-Yun Ma; Lei Hu; Yong-Ning Lv; Hong Huang; Jia-Qiang Xu; Dan-Dan Huang; Rui-Jie Liu; Yong Han; Yu Zhang | |
刊名 | International journal of clinical oncology
![]() |
2019 | |
关键词 | Lung cancer Platinum-based chemotherapy Prognosis STAT3 rs4769793 Susceptibility |
ISSN号 | 1437-7772 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4736907 |
专题 | 湖南大学 |
作者单位 | 1.Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Department of Pharmacy, Peking University People's Hospital, 100044, Beijing, China. Wuhan Highway Management Office, Wuhan, 430000, China. Department of Nursing, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410008, China. Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. sanlan2000@16 2.com. |
推荐引用方式 GB/T 7714 | Wei-Jing Gong,Li-Yun Ma,Lei Hu,et al. STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy.[J]. International journal of clinical oncology,2019. |
APA | Wei-Jing Gong.,Li-Yun Ma.,Lei Hu.,Yong-Ning Lv.,Hong Huang.,...&San-Lan Wu.(2019).STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy..International journal of clinical oncology. |
MLA | Wei-Jing Gong,et al."STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy.".International journal of clinical oncology (2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论